The 9th
in the series of WACEM-ACAIM Joint Group Meeting was packed with presentations
of important work being done by the group. Our continued gratitude to all presenters
and panelists.
COVID19 ~Multi-System Dysfunction Syndrome also called Multi-System Inflammatory Syndrome in Children & Adolescents
We
have in detail discussed that COVID is an Immunological Syndrome like HIV and
our thought process was further validated by The World Health Organization.
We
further profess that there is a strong possibility that COVID will be a chronic
immunological disease which will need immunological and anti-viral intervention
in combinations rather than individually.
Personalized
COVID Therapy Options will need to be devised as COVID generates a personalized
reaction in every patient.
The
Term “Multi-System Dysfunction”
was a term, which was apt for COVID and the personalized response it generates
in humans at different ages.
Immunotherapeutic Anti-Virals
COVID
and Flu are going to have a devastating effect on population. The synergistic
antigenicity will be highlighted by the heightened immune response both by the
direct and indirect pathway. IL6 will play a major role and will emerge as a
target for therapy.
Immunotherapy
Options will need to be addressed aggressively as we near the Flu Season. A
detail discussion was held on the role of plasma therapy as well early cell
therapy in acute viral diseases with multi-organ failure and shock.
ECMO in COVID
The
role of cardiothoracic surgeons supersedes intensivist in the provision of ECMO
in COVID. Discussion
as regards induction and phase out criteria for ECMO was done.
Supply
Chains BioSecurity
Presentations were done on Biosecurity of Medical and Survival supply
chains.
It was deducted that a clear focus was to be laid on creating benchmarks
to evaluate the security standards of all medical and survival supplies as a
part of healthcare and public health.
POC
Biomarkers in COVIFLU
Aggressive use of Point of Care Testing was found to be crucial
for COVID patient care. Troponin, BNP, ABG and Bedside Chem 8 and lactates were
found to not only decrease time but also fasten effective care. New Emerging
biomarkers were discussed in detail including immunological markers.
Oxygen
Therapeutics
The Group had a detail discussion on the collective wisdom being
applied in developing diagnostic, therapeutic as well as home monitoring
benchmarks in Oxygenation Therapy.
Our COVID Publications:
Detailed
CORONAVIRUS Primer
Silent Hypoxia Algorithm
Crisis TeleMedicine
No comments:
Post a Comment